BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/10/2015

FDA Announces Draft Recommendations for Triethylamine and Methylisobutylketone Residual Solvents

The FDA is releasing draft guidelines for the acceptable daily exposure limits of triethylamine and methylisobutylketone in pharmaceuticals, in line with the International Conference on Harmonisation's (ICH) technical requirements for pharmaceutical registration.

Source: Federal Register — Food and Drug AdministrationOpen original release →